Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia
Value in Health - United Kingdom
doi 10.1016/j.jval.2016.08.280
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2016
Authors
Publisher
Elsevier BV